Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Boehringer Ingelheim sees flat sales in 2014

Country: Germany

Generic competition and difficult market conditions in Germany are expected to weigh on Boehringer Ingelheim GmbH’s business this year with the result that net sales will likely be unchanged from the €14.1 billion reported in 2013.

Read more

New US indication for Arzerra

Country: United Kingdom

The US Food and Drug Administration has approved a new first-line indication for Arzerra (ofatumumab), a CD20-directed monoclonal antibody. This is for use in combination with chlorambucil for chronic lymphocytic leukaemia (CLL) in patients who can’t receive fludarabine.

Read more

FDA approves third allergy tablet

Country: United States

Read more

Actelion expands its PAH franchise in first quarter

Country: Switzerland

Read more

OxThera get funding for orphan project

Country: Sweden

Read more

BioAlliance and Topotarget to merge

Country: France

Read more

Wilson Therapeutics gets B-round financing

Country: Sweden

Read more

FDA approves second allergy tablet

Country: United States

Read more

FDA approves albiglutide

Country: United Kingdom

Read more

Roche expects earnings to beat sales

Country: Switzerland

Read more

French gene therapy raises $12 million

Country: France

Read more

Cytos asthma trial fails

Country: Switzerland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Why the UK is building cell therapy capacity by Keith Thompson

CommentaryKeithThompsonApr14.pdf

Highlights of the April 2014 MedNous issue

The April 2014 MedNous features:

Latest Mednous cover
  • Business Strategy
    Revolution afoot
    for allergy therapies
  • Interview
    Ewan Birney discusses
    Big Data and drug
    target validation
  • Commentary
    How drug development
    can be shortened
    By Christian Gr√łndahl and Glenn A Friedrich
  • Commentary
    Why the UK is building cell therapy capacity
    By Keith Thompson
  • Markets
    European biotechs gain European IPO window opens

The latest MedNous journal. Subscribe to download.

Recent Appointments